PsyMuKB

PPI network (data source: BioGrid)

A gene is determined as “expressed” when its expression values are above the pre-determined cutoff, which is the mean normalized expression(base 2 log of (TPM+1)) +1 in all brain tissue from GTEx v7 or BrainSpan data.

A protein is determined as “expressed” when its expression values are above the pre-determined cutoff, which is the normalized expression (base 10 log of iBAQ intensity) ≥0.5 in at least one brain tissue from ProteomicsDB data. Otherwise, a gene or protein is determined as either with below-cutoff expressions or no available data.

	The queried gene/protein
	The interacting partner is expressed at mRNA-level
	The interacting partner is expressed at protein-level
	The interacting partner is expressed at both mRNA and protein level
	The interacting partner is with either below-cutoff expressions or no expression data at both mRNA and protein level
	The interacting partner is hit by coding DNMs
	Physical interaction between queried gene/protein and its partner
	Physical interaction between two interacting partners

Symbol A	GeneA coding DNM count	Symbol B	GeneB coding DNM count	Interaction detection method	Publication	Evidence
GNAI2	1	GNAI3	0	biochemical, affinity chromatography technology, affinity chromatography technology	Havugimana PC (2012), Huttlin EL (2015), Huttlin EL (2017)	3
POT1	2	RGS14	2	two hybrid	Lee OH (2011)	1
RND2	0	RGS14	2	affinity chromatography technology	Goh LL (2012)	1
RGS14	2	GNA11	2	pull down	Sammond DW (2007)	1
RGS14	2	WAS	0	two hybrid	Wang J (2011)	1
GNAI1	10	RGS14	2	pull down, x-ray crystallography, two hybrid, pull down, two hybrid, affinity chromatography technology, affinity chromatography technology	Kimple RJ (2001), Kimple RJ (2002), Kimple RJ (2001), Sammond DW (2010), Wang J (2011), Huttlin EL (2015), Huttlin EL (2017)	7
RGS14	2	RAP2A	0	pull down	Traver S (2000)	1
POT1	2	TINF2	1	affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology, far western blotting, two hybrid, two hybrid, affinity chromatography technology, affinity chromatography technology, affinity chromatography technology	Ye JZ (2004), Ye JZ (2004), Liu D (2004), Loayza D (2003), Loayza D (2003), Giannone RJ (2010), Liu D (2004), Liu D (2004), Ye JZ (2004), Lee OH (2011), Lee OH (2011), Hein MY (2015), Hein MY (2015), Huttlin EL (2017)	14
RND3	0	RGS14	2	affinity chromatography technology	Goh LL (2012)	1
GNAI3	0	RGS14	2	pull down, two hybrid, two hybrid, affinity chromatography technology, affinity chromatography technology	Kimple RJ (2001), Kimple RJ (2001), Wang J (2011), Huttlin EL (2015), Huttlin EL (2017)	5
RGS14	2	RAP1A	1	pull down	Traver S (2000)	1
GNAI1	10	GNAI3	0	biochemical, affinity chromatography technology, affinity chromatography technology	Havugimana PC (2012), Huttlin EL (2015), Huttlin EL (2017)	3
GNAI3	0	XPO1	8	biochemical	Kristensen AR (2012)	1
XPO1	8	NFKB1	2	affinity chromatography technology	Kirli K (2015)	1
GNAI1	10	GNAI2	1	biochemical	Havugimana PC (2012)	1
TINF2	1	RGS14	2	two hybrid	Lee OH (2011)	1
RND1	0	RGS14	2	affinity chromatography technology	Goh LL (2012)	1
TRAF2	1	RGS14	2	two hybrid	Rual JF (2005)	1
RGS14	2	APP	1	pull down	Olah J (2011)	1
RGS14	2	GNAI2	1	two hybrid	Kimple RJ (2001)	1
NFKB1	2	RGS14	2	two hybrid	Wang J (2011)	1
RGS14	2	XPO1	8	two hybrid	Wang J (2011)	1